AIDS 2014: Meeting of NHMRC study collaborators

Burnet Institute

19 July, 2014

The study collaborators at Burnet Institute following the meeting.

International collaborators on a Burnet Institute–led study investigating the acceleration of antiretroviral initiation in mothers and infants have met in Melbourne ahead of AIDS 2014.

The study hopes to improve maternal and child health in the Asia and Pacific regions by increasing uptake and timely initiation of lifesaving antiretroviral therapy for HIV-infected pregnant women and their infants.

It will provide, for the first time, evidence of the effectiveness, feasibility and acceptability of the Burnet-developed VISITECT® CD4 test among HIV-infected pregnant women during antenatal care and the POC LYNX HIV p24 early infant diagnostic test among HIV exposed infants in Myanmar, Papua New Guinea (PNG) and China.

Burnet’s Associate Professor Stanley Luchters is leading the study, which will collaborate with local partners in nine sites across the three countries.

“Trialling these POC interventions in low-prevalence settings in Myanmar, PNG and China will provide novel data to guide their implementation and enhance global coverage of lifesaving therapy,” Associate Professor Luchters said.

“Having AIDS 2014 in Melbourne, has given us this wonderful opportunity to bring the study investigators together for this one-day investigator meeting, and should be a great start to an interesting week of networking and knowledge exchange.”

Contact Details

For more information in relation to this news article, please contact:

Burnet Institute

[email protected]




Subscribe to News

Subscribe to receive our latest news: